Tumori 2005;91(2):135-138
The study highlighted the potential of GLP-1 agonists in altering the brain's response to cocaine, suggesting that these medications could be used as part of a comprehensive treatment plan for stimulant addiction (Hernandez et al., 2018)
Type 2 diabetes, which is more prevalent and often linked to lifestyle factors, contributes significantly to the market, with treatments focused on oral medications, GLP-1 receptor agonists, DPP-4 inhibitors, and SGLT2 inhibitors
Wegovy and Weight Loss Wegovy (semaglutide) is FDA-approved to lower the risk of cardiovascular events like stroke or heart attack in people with obesity and underlying heart disease
They target different aspects of the healing process, which is why they're often combined